LENSAR, Inc. reported financial results for the fiscal quarter ended June 30, 2026, achieving total revenue of $16.5 million, an 18% increase from the prior year period. Recurring revenue grew 20% to $13.7 million, driven by a 23% rise in procedure revenue to $10.2 million and a 13% increase in procedure volume to 58,682. The company reported its first positive net income of $3.5 million and an Adjusted EBITDA of $3.6 million for the quarter. Operational highlights include placing 10 ALLY Robotic Cataract Laser Systems during the quarter, bringing the total installed base to 445 systems with a backlog of 13 pending installations. LENSAR operates in the medical technology industry, designing and marketing advanced robotic laser solutions for cataract treatment.